COVID-19: New Brunswick Pauses First Doses of AstraZeneca Vaccine – May 13, 2021

COVID-19: Canada Responds

COVID-19: New Brunswick Pauses First Doses of AstraZeneca Vaccine – May 13, 2021

In Fredericton, Dr. Jennifer Russell, New Brunswick’s chief medical officer of health, and Dominic Cardy, New Brunswick’s minister of education and early childhood development, provide an update on the province’s response to the ongoing COVID-19 (coronavirus disease) pandemic. Dr. Russell announces that the province will pause the administering of first doses of the AstraZeneca COVID-19 vaccine. Her announcement comes as New Brunswick confirms two additional cases of blood clots linked to that vaccine for a total of four cases. The province will still accept 13,500 doses of AstraZeneca next week. The vaccine will be used as second doses for those who are 55 and older who are homebound and cannot access another vaccine. Individuals must provide their informed consent. Dr. Russell also announces that people 30 and older may now book an appointment online to receive their first dose of a COVID-19 vaccine. New Brunswick is the latest province to announce it is suspending the use of the AstraZeneca for first doses, either due to blood clot concerns or supply issues. (no interpretation)